Published in

Nature Research, npj Breast Cancer, 1(9), 2023

DOI: 10.1038/s41523-023-00520-7

Links

Tools

Export citation

Search in Google Scholar

The dilemma of selecting a first line CDK4/6 inhibitor for hormone receptor-positive/HER2-negative metastatic breast cancer

Journal article published in 2023 by Albert Grinshpun ORCID, Sara M. Tolaney ORCID, Harold J. Burstein, Rinath Jeselsohn ORCID, Erica L. Mayer ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO